Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2018, Article ID 6483605, 5 pages
Case Report

Hepatotoxicity Associated with Use of the Weight Loss Supplement Garcinia cambogia: A Case Report and Review of the Literature

1Nazih Zuhdi Transplant Institute, INTEGRIS Baptist Medical Center, 3300 NW Expressway, Oklahoma City, OK 73112, USA
2Department of Internal Medicine, Coney Island Hospital, 2601 Coney Island Avenue, Brooklyn, NY 11235, USA
3Division of Gastroenterology and Hepatology, Louisiana State University Health Sciences Center, Shreveport, LA 71103, USA
4Department of Gastroenterology and Hepatology, University of Nebraska Medical Center, 982000 Nebraska Medical Center, Omaha, NE 68198, USA

Correspondence should be addressed to Jiten P. Kothadia; moc.liamg@netij.aidahtok

Received 28 October 2017; Revised 3 January 2018; Accepted 31 January 2018; Published 12 March 2018

Academic Editor: Fumio Imazeki

Copyright © 2018 Jiten P. Kothadia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The use of herbal and dietary supplements for weight loss is becoming increasingly common as obesity is becoming major health problem in the United States. Despite the popularity of these natural supplements, there are no guidelines for their therapeutic doses and their safety is always a concern. Garcinia cambogia extract with its active ingredient “hydroxycitric acid” is a component of many weight loss regimens. It suppresses fatty acid biosynthesis and decreases appetite. However, its prolonged use in weight maintenance is unknown. Here we describe a case of acute hepatitis after the use of Garcinia cambogia for weight loss.